Earnings
Key Metrics
Income Statement
Balance Sheet
Cash Flow
Shareholder Return
Reporting period: 2025.04.01-2026.03.31
Summary: JU FU TANG BIOT (08217) reported Revenue of 33.16M(-8.41%); Operating profit of 21.22M(+509.82%); Net profit attributable to owners of 20.59M(+449.02%).
Reported YoY
Prior Year YoY
Net profit attributable to owners Up YoY
Net profit attributable to owners
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Gross margin
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 1.12% -- -2.75% 3.88%5.35% 8.10%2.71% 2.64%2.71% 0.00%
Net margin
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -21.72% -- -9.52% 12.20%-49.61% 40.08%-16.29% 33.31%62.09% 78.38%
ROE
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -33.29% -- -19.71% 13.58%-52.64% 32.93%-21.67% 30.97%46.14% 67.82%
ROA
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -13.96% -- -9.44% 4.51%-21.38% 11.93%-7.36% 14.02%25.18% 32.53%
Revenue growth
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 21.73% -- -65.21% 86.94%13.64% 78.85%-8.41% 22.04%
Attributable profit growth
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 46.62% -- -81.20% 127.82%62.67% 143.88%449.02% 386.35%
Debt-to-assets
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 58.08% -- 52.09% 5.99%59.39% 7.30%66.27% 6.87%45.43% 20.83%
Current ratio
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 1.71 -- 1.91 0.211.68 0.241.51 0.172.20 0.69
Operating cash flow / net profit
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 0.97 -- -3.24 4.20-0.21 3.021.14 1.350.33 0.80
Operating cash flow / revenue
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -21.04% -- 30.81% 51.85%10.59% 20.22%-18.53% 29.12%20.80% 39.33%
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Revenue
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 75.22M -- 91.57M 21.73%31.86M 65.21%36.20M 13.64%33.16M 8.41%
Other income and gains
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 96.51K -- 3.73M 3766.82%1.08M 71.14%1.39M 29.25%10.60K 99.24%
Cost of sales
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 35.22M -- 36.54M 3.74%
Gross profit
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 845.88K -- -2.52M 397.85%1.70M 167.65%982.00K 42.38%897.96K 8.56%
Administrative expenses
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 8.62M -- 5.08M 41.10%6.86M 35.11%9.35M 36.34%7.53M 19.51%
Net finance costs
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 594.47K -- 631.17K 6.17%652.72K 3.41%720.00K 10.31%635.72K 11.71%
Income tax
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 49.47K -- -- -- -- -- 0 -- 0 --
Operating profit
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -15.79M -- -8.09M 48.78%-15.15M 87.27%-5.18M 65.82%21.22M 509.82%
Profit before tax
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -16.39M -- -8.72M 46.78%-15.80M 81.20%-5.90M 62.67%20.59M 449.02%
Net profit
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -16.34M -- -8.72M 46.62%-15.80M 81.20%-5.90M 62.67%20.59M 449.02%
Net profit attributable to owners
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -16.34M -- -8.72M 46.62%-15.80M 81.20%-5.90M 62.67%20.59M 449.02%
Cash and cash equivalents YoY
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Cash and cash equivalents
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 6.65M -- 7.14M 7.30%3.63M 49.12%2.11M 41.80%8.19M 287.61%
Trade and bills receivables
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 44.80M -- 30.66M 31.56%34.17M 11.45%34.25M 0.23%18.12M 47.10%
Total current assets
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 115.97M -- 92.09M 20.60%73.71M 19.95%80.20M 8.80%81.77M 1.96%
Total assets
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 117.07M -- 92.37M 21.10%73.93M 19.96%80.20M 8.48%81.77M 1.96%
Total current liabilities
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 67.99M -- 48.12M 29.23%43.91M 8.74%53.15M 21.03%37.15M 30.10%
Total liabilities
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 67.99M -- 48.12M 29.23%43.91M 8.74%53.15M 21.03%37.15M 30.10%
Equity attributable to owners
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 49.08M -- 44.25M 9.83%30.02M 32.16%27.22M 9.34%44.62M 63.94%
Total equity
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 49.08M -- 44.25M 9.83%30.02M 32.16%27.22M 9.34%44.62M 63.94%
Net cash from operating activities YoY
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Net cash from operating activities
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -15.83M -- 28.22M 278.28%3.37M 88.04%-6.71M 298.83%6.90M 202.79%
Net cash from investing activities
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 72.99K -- 705.58K 866.67%-- -- -- -- 6.18M --
Net cash from financing activities
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 9.78M -- -28.96M 396.29%-7.13M 75.37%4.96M 169.57%-6.75M 235.96%
Net change in cash
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -5.98M -- -42.90K 99.28%-3.76M 8664.32%-1.75M 53.56%6.32M 462.23%
Dividend Details
Dividend Details
Ex-date
Payment Date
Record Date
5 : 1
Share Consolidation
建议股本重组(每5股合并为1股,并将法定未发行合并股份拆细为50股经调整股份)及按每1股经调整股份获发3股供股股份进行供股,认购价0.32港元,最多发行181,116,000股,筹集约58.0百万港元,记录日期2027-02-19,除权日2027-02-11,股本重组生效日2026-12-17。
2027-02-11
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows JU FU TANG BIOT (08217) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.
Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect